University of Missouri launches first on-campus radiopharmaceutical clinical trial
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
Normal BMI hides nutritional gaps in alcohol use disorder
A sweeping review shows that while calorie intake and BMI often appear normal in people with alcohol use…
Dynamic viral markers predict treatment response in hepatitis B
Background and aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in…
ERC Proof of Concept grant supports promising CRISPR-based cancer treatment research
Microbiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept…
Bacterial infections in patients with liver cirrhosis show rising prevalence and high mortality
Background and aims Bacterial infections (BIs) are common and severe complications in patients with liver cirrhosis, but global…
New study identifies the optimal exercise dose for reducing hepatic steatosis
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives…
Expert guidance on fecal microbiota transplantation in liver disease
The gut microbiota plays a crucial role in maintaining host health and liver function. Fecal microbiota transplantation (FMT),…
Study shows DHPS enzyme controls macrophage maturation across multiple organs
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…
Researchers discover how Mycoplasma pneumoniae acquires cholesterol from human hosts
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae-responsible for atypical pneumonia…
Gut bacteria compound during pregnancy protects offspring from fatty liver disease
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk…
Preclinical study reveals potential new treatment for severe liver fibrosis
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis – a dangerous, disease-induced build-up of…
‘The great silent epidemic we’re facing is fatty liver disease and it’s going to get worse’
Friday, 2 January 2026, 16:42 Raúl Andrade, head of digestive medicine at Malaga’s Hospital ClÃnico, is also a…